---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-24-000055"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2024-07-08T23:59:59+00:00"
generated_at: "2026-05-31T22:47:48.236191+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# West enters $130M incremental term loan to refinance existing debt and notes

## Summary
- On July 2, 2024, West Pharmaceutical Services entered a Third Amendment to its Credit Agreement, establishing a $130.0 million incremental term loan.
- The new term loan was fully drawn at closing and matures on July 2, 2027, with no scheduled amortization.
- Proceeds repaid an outstanding ~$80 million term loan and ~$53 million of 3.82% Series B Senior Notes due July 5, 2024.
- Interest at closing is 3-month SOFR plus 1.250%, with margins ranging from 1.250% to 1.625% based on net leverage ratio.
- Mandatory prepayments apply for asset sales and non-permitted debt issuances; optional prepayments are allowed.

## SEC filing metadata
- accession: 0000105770-24-000055
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2024-07-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577024000055/0000105770-24-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577024000055/wst-20240702.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-24-000055
- JSON: https://secwatch.observer/filing/0000105770-24-000055.json
- Plain text: https://secwatch.observer/filing/0000105770-24-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.